Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Thor Medical ASA (TRMED) - Total Liabilities
Latest total liabilities as of June 2025: Nkr87.50 Million NOK
Based on the latest financial reports, Thor Medical ASA (TRMED) has total liabilities worth Nkr87.50 Million NOK as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Thor Medical ASA - Total Liabilities Trend (2019–2024)
This chart illustrates how Thor Medical ASA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Thor Medical ASA Competitors by Total Liabilities
The table below lists competitors of Thor Medical ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LightInTheBox Holding Co Ltd ARD
NYSE:LITB
|
USA | $72.58 Million |
|
Transat A.T. Inc
PINK:TRZBF
|
USA | $3.22 Billion |
|
Ilshinstone
KO:007110
|
Korea | ₩34.89 Billion |
|
Hwa Sung Ind
KO:002460
|
Korea | ₩325.72 Billion |
|
Cinclus Pharma Holding AB (publ)
F:J8P
|
Germany | €157.99 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Thor Medical ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thor Medical ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thor Medical ASA (2019–2024)
The table below shows the annual total liabilities of Thor Medical ASA from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr77.30 Million | +31.22% |
| 2023-12-31 | Nkr58.91 Million | +28.62% |
| 2022-12-31 | Nkr45.80 Million | -70.67% |
| 2021-12-31 | Nkr156.16 Million | +14.87% |
| 2020-12-31 | Nkr135.94 Million | +2874.01% |
| 2019-12-31 | Nkr4.57 Million | -- |